![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07C 235/34 | |
A61K 31/165 | |||
A61P 9/12 | |||
A61P 13/12 |
(11) | Number of the document | 3046901 |
(13) | Kind of document | T |
(96) | European patent application number | 14845373.1 |
Date of filing the European patent application | 2014-09-17 | |
(97) | Date of publication of the European application | 2016-07-27 |
(45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/AU2014/000923 |
Date | 2014-09-17 |
(87) | Number | WO 2015/039173 |
Date | 2015-03-26 |
(30) | Number | Date | Country code |
2013903573 | 2013-09-17 | AU |
(72) |
DUGGAN, Karen Annette, AU
|
(73) |
Vectus Biosystems Limited,
3-11 Primrose Avenue, Rosebery, NSW 2018,
AU
|
(54) | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS |
COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS |